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A rare histone modification, arginine methylation,
has been linked to activation of hormone-respon-
sive genes. Interestingly, methylation of a lysine
residue in the same histone is present prior to
hormone activation, but is excluded from the
active loci.
Post-translational modification of histones plays a
central role in the regulation of gene expression.
Histone acetylation, in particular, is linked to gene
activation, whereas deacetylation is linked to repres-
sion. Histone phosphorylation is connected not only to
gene activation, but also to chromosome condensa-
tion and DNA repair. Histones are subject to ubiquiti-
nation and methylation as well, but the functions of
these modifications are poorly understood. In general,
histone modifications are thought to affect both the
structure of chromatin and its interactions with non-
histone regulatory factors. Recent studies have shown
that the relatively rare histone modification of arginine
methylation can play an important role in the
transcriptional activation of certain genes.
Histone Methylation
Although histone methylation has long been observed
in a number of organisms, only recently have specific
roles for this modification come to light. The known
sites for histone H3 methylation and the enzymes
identified are summarized in Figure 1a. The most
studied methylation event occurs on Lys9 of histone
H3 and is mediated by members of the Su(var)3-9
family of methyltransferases. This family of methyl-
transferases was originally identified in Drosophila
(Su(var)3-9), and homologs have been described in
S. pombe (Clr4), mice (Suv39h1 and Suv39h2) and
humans (SUV39H1). A characteristic feature of pro-
teins in this family is the presence of a ‘SET’ domain.
Methylation of residue Lys9 of histone H3 is strongly
associated with gene silencing and the formation of
heterochromatin [1,2]. This modification creates a
binding site for heterochromatin-specific proteins,
such as HP1. Interestingly, HP1 also binds to the
methyltransferase Su(var)3–9, providing the possibility
for feedback regulation as well as for the spread of the
H3 Lys9 methylation and HP1 binding to neighboring
nucleosomes. Histone H3 Lys9 methylation may also
function in repression outside of heterochromatin, as
SUV39H1 can cooperate with the Rb protein in repres-
sion of euchromatic genes [3].
Disruption of both mouse genes Suv39h1 and
Suv39h2 causes severely reduced viability and chro-
mosome instabilities which lead to increased tumor
formation and spermatogenic failure [4]. The chromo-
somal instability in these mice highlights the impor-
tance of this histone modification in the establishment
of heterochromatin, and moreover the importance of
proper heterochromatin maintenance. Intriguingly, two
antibodies specific for Lys9-methylated isoforms of
histone H3 were used to characterize the double
Suv39h1-h2 mutant mice. One antibody exhibited high
specificity towards pericentric heterochromatin and
lost reactivity in the double null mice, as expected; the
second antibody exhibited a more diffuse staining
pattern that was not abolished. These results suggest
that additional, unidentified histone methyltrans-
ferases can methylate this residue outside of pericen-
tric heterochromatin, suggesting additional functions
for histone H3 Lys9 methylation. 
Histone H3 can also be methylated at Lys4, but the
function of this modification is as yet poorly under-
stood. This modification is associated with the tran-
scriptionally active macronucleus of Tetrahymena [5].
In the fission yeast Schizosaccharomyces pombe,
methyl-histone H4 Lys4 is found in euchromatic regions
and appears in an exclusive, complementary pattern
with methyl-histone H3 Lys9 [6]. A similar relationship
is observed at the chicken β-globin locus, where
methyl-histone H3 Lys4 is anticorrelated with methyl-
histone H3 Lys9, but correlates well with histone H3
acetylation [7]. 
Interestingly, histone H3 Lys9 methylation has 
not been detected in the budding yeast Saccha-
romyces cerevisiae, which has very little heterochro-
matin, but histone H3 Lys4 methylation is abundant.
No Su(var)3–9 family member is readily apparent in the
S. cerevisiae genome, but up to six genes (SET1-6)
encoding proteins with SET domains have been iden-
tified. Set1 methylates histone H3 at Lys4 in vitro, and
both SET1 and histone H3 Lys4 methylation are
required for complete rDNA silencing [8]. It will be very
interesting to determine whether S. cerevisiae uses
Lys4 in gene silencing and the formation of hete-
rochromatin-like structures as other organisms use
Lys9, or whether the methylation of each of these sites
has multiple functions in gene activation and repres-
sion. Another family member, Set2, methylates histone
H3 Lys36, and appears to have a repressive function
in vivo [9].
Until recently, little was known about the role of
arginine methylation of the histones. The significance
of this modification has been questionable, because it
occurs rarely and is present at very low abundance.
However, the discovery of two histone arginine
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methyltransferases, CARM1 and PRMT1, as cofactors
required for responses to nuclear receptor hormones
provided an indication that histone arginine methyla-
tion does have an important role in transcriptional reg-
ulation [10]. 
Hormone-dependent Activation
Activation of transcription mediated by nuclear recep-
tors is a complex, multistep process [11]. As illus-
trated in Figure 1b, ligand-bound nuclear receptors
bind specific enhancer elements and recruit coactiva-
tors of the p160 family (SRC-1, GRIP1, ACTR). These
co-activators recruit secondary coactivators including
histone acetylases (p300, CBP) and arginine-specific
protein methyltransferases (CARM1, PRMT1). Activa-
tion of hormone-responsive genes clearly requires
chromatin remodeling and modification, and unravel-
ing the co-factors and identifying the histone modifi-
cations involved is a major research focus.
In transient transfection assays with hormone-
responsive reporter genes, multiple co-factors with
chromatin modifying activities were found to function
synergistically to achieve high levels of transcription.
In the presence of a p160 co-activator, for example,
CARM1 and p300 function together to yield a higher
level of activation than can be achieved by either
factor alone [12]. The same is true for CARM1 and
PRMT1 [13]. Acetylation of multiple lysines within the
core histones by p300 may act cooperatively with
methylation of specific arginine residues in H3 by
CARM1. Such cooperation appears to be the case for
PRMT1. In vitro, PRMT1-methylated histone H4 is a
better substrate for the histone acetyltransferase p300
and, conversely, the acetylated tail is a poor substrate
for PRMT1 [14]. Even the two arginine methyltrans-
ferases involved in these responses have distinct
histone targets that may each contribute gene activa-
tion. CARM1 methylates H3 Arg17 and Arg26 [15],
while PRMT1 methylates histone H4 Arg3 [14,16].
One limitation of transient transfection experiments
is the inefficient packaging of the reporter genes into
chromatin. Several studies have documented the
importance of chromatin for proper regulation by the
nuclear receptors. For example, mouse mammary
tumor virus (MMTV) reporters only respond properly to
glucocorticoids when assembled into chromatin tem-
plates [17]. To avoid such problems, Hager and col-
leagues [18] have developed cell lines with large,
tandemly integrated reporters carrying MMTV pro-
moters. One cell line in particular is an exceptionally
powerful tool, as the integrated MMTV array is large
enough to be visualized by light microscopy after DNA
staining. Immunocytofluorescence using antibodies to
specific transcription factors or histone isoforms also
allows visualization of active transcription, receptor
binding and specific histone modification states.
As recently reported in Current Biology [19], Ma
et al. took advantage of this powerful system to
demonstrate the molecular synergy between GRIP1
and CARM1 in nuclear receptor responses. They
showed that GRIP1 and CARM1 cooperate to
enhance hormone-dependent activation of multiple
tandemly integrated copies of a CAT reporter gene
controlled by the MMTV promoter. Effects of specific
mutations showed that the methyltransferase activity
of CARM1 is necessary for its co-activator function.
CARM1 and the CARM1-methylated form of H3 (methyl
Arg17) associated with the MMTV promoter in a
hormone-dependent manner. Conversely, methylation
of histone H3 Lys4 was found to be excluded from the
array upon hormone activation.
Dynamics of Histone Methylation: Is It
Reversible?
An exciting implication of these results [19] is that
histone methylation is dynamic. No histone demethy-
lating activities have been discovered to date, ques-
tioning the reversibility of the modification. Some
models suggest that proteolytic cleavage of the
histone tails, or replacement of the entire methylated
histone, is necessary to remove this mark from chro-
matin [20]. However, the presence of histone H3 Lys4
methylation in the absence of hormone treatment, the
rapid exclusion of this modification upon hormone
treatment and the concomitant gain of a new methy-
lation mark a few amino acids downstream (at Arg17)
strongly indicate that at least some methylation events
are reversible. In this case, proteolysis of the H3 tail
would have to be extremely limited to prevent removal
of both Lys4 and Arg17. Replacement of the modified
Figure 1.
(A) Methylation sites in the histone H3 tail, the enzymes identi-
fied to methylate these sites (top), and potential roles ascribed
to the modified sites (bottom). (B) A schematic model for
hormone-dependent transcriptional activation. The nuclear
hormone receptor (NR) –ligand (L) complex binds to a hormone
response element (HRE). The NR recruits coactivators (GRIP1,
SRC-1, ACTR) which then recruit secondary coactivators (CBP,
p300 and CARM1, PRMT1). CBP and p300 can acetylate all
four core histone tails. PRMT1 and CARM1 methylate H4 and
H3 tails, respectively. Although shown here on separate mol-

















































histone — by reassembly of nucleosomes associated
with the array — would also have to be very rapid.
Using the system described by Ma et al. [19], time
course studies of histone H3 methylation dynamics
should be revealing as to the mechanism of the
‘methylation exchange’ and may provide a new tool in
the search for the elusive histone demethylase (or pro-
teolytic) activities. 
The complex network of histone modifications that
occur in nuclear receptor-mediated gene activation
strongly support the existence of a ‘histone code’: the
concept that the specific modification state of the his-
tones plays crucial, specific regulatory roles and thus
extends the information content of the genome past
the DNA code [20]. The complexity of functions asso-
ciated with the modifications within this single histone,
H3, in nuclear hormone-dependent activation high-
lights the immense regulatory potential of chromatin.
Each histone has multiple sites of modification, so
thousands of combinations are possible. The challenge
for the future is to decipher this circuitry and under-
stand how each type and site of histone modification
signals the appropriate response. The powerful in vivo
system used by Ma et al. [19] will be an important tool
in addressing many crucial questions about the regu-
latory role of histone methylation, the relationship
between histone methylation and acetylation, and how
these individual modifications lead to gene activation. 
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